Literature DB >> 15356460

Intravenous bisphosphonates and osteonecrosis.

Martin S Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15356460     DOI： 10.1016/j.tripleo.2004.08.001

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN： 1079-2104


× No keyword cloud information.
  22 in total

1.  Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws.

Authors:  Thomas Mücke; Janett Koschinski; Herbert Deppe; Stefan Wagenpfeil; Christoph Pautke; David A Mitchell; Klaus-Dietrich Wolff; Frank Hölzle
Journal:  J Cancer Res Clin Oncol       Date:  2010-10-07       Impact factor: 4.553

2.  Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma.

Authors:  Kazuho Shimura; Chihiro Shimazaki; Kyoko Taniguchi; Sonoko Akamatsu; Masashi Okamoto; Ryo Uchida; Ken-ichi Nomura; Tohru Inaba; Shigeo Horiike; Narisato Kanamura; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

3.  [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

Authors:  S Hoefert; H Eufinger
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

Review 4.  [Palliative and supportive treatment options in patients with advanced prostate cancer].

Authors:  T Maurer; M Retz; J E Gschwend
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 5.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 6.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

Review 7.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

8.  [Necrosis of the jaws under bisphosphonate therapy].

Authors:  S Hoefert; H Eufinger
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

9.  Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis.

Authors:  Miguel Luciano Silva; Leandro Tasso; Alan Arrieira Azambuja; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Vinicius Duval da Silva; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

10.  Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up.

Authors:  Philipp Stockmann; Eleftherios Vairaktaris; Falk Wehrhan; Martin Seiss; Stephan Schwarz; Bernd Spriewald; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Support Care Cancer       Date:  2009-07-17       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.